vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Latham Group, Inc. (SWIM). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $117.3M, roughly 1.8× Latham Group, Inc.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -7.3%, a 15.5% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 5.3%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -14.4%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Latham & Watkins LLP is an American multinational law firm. Founded in 1934 in Los Angeles, California, it is known for its litigation, corporate, and regulatory law practices.
COLL vs SWIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $117.3M |
| Net Profit | $17.0M | $-8.5M |
| Gross Margin | 62.5% | 31.7% |
| Operating Margin | 29.6% | — |
| Net Margin | 8.3% | -7.3% |
| Revenue YoY | 12.9% | 5.3% |
| Net Profit YoY | 35.3% | -43.1% |
| EPS (diluted) | $0.48 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $117.3M | ||
| Q4 25 | $205.4M | $100.0M | ||
| Q3 25 | $209.4M | $161.9M | ||
| Q2 25 | $188.0M | $172.6M | ||
| Q1 25 | $177.8M | $111.4M | ||
| Q4 24 | $181.9M | $87.3M | ||
| Q3 24 | $159.3M | $150.5M | ||
| Q2 24 | $145.3M | $160.1M |
| Q1 26 | — | $-8.5M | ||
| Q4 25 | $17.0M | $-7.0M | ||
| Q3 25 | $31.5M | $8.1M | ||
| Q2 25 | $12.0M | $16.0M | ||
| Q1 25 | $2.4M | $-6.0M | ||
| Q4 24 | $12.5M | $-29.2M | ||
| Q3 24 | $9.3M | $5.9M | ||
| Q2 24 | $19.6M | $13.3M |
| Q1 26 | — | 31.7% | ||
| Q4 25 | 62.5% | 28.0% | ||
| Q3 25 | 61.7% | 35.4% | ||
| Q2 25 | 57.7% | 37.1% | ||
| Q1 25 | 54.8% | 29.5% | ||
| Q4 24 | 54.0% | 24.6% | ||
| Q3 24 | 60.8% | 32.4% | ||
| Q2 24 | 62.5% | 33.1% |
| Q1 26 | — | — | ||
| Q4 25 | 29.6% | -10.7% | ||
| Q3 25 | 29.7% | 13.3% | ||
| Q2 25 | 18.7% | 14.3% | ||
| Q1 25 | 12.2% | -4.4% | ||
| Q4 24 | 20.9% | -14.9% | ||
| Q3 24 | 21.9% | 8.9% | ||
| Q2 24 | 32.7% | 12.5% |
| Q1 26 | — | -7.3% | ||
| Q4 25 | 8.3% | -7.0% | ||
| Q3 25 | 15.0% | 5.0% | ||
| Q2 25 | 6.4% | 9.3% | ||
| Q1 25 | 1.4% | -5.4% | ||
| Q4 24 | 6.9% | -33.4% | ||
| Q3 24 | 5.9% | 3.9% | ||
| Q2 24 | 13.5% | 8.3% |
| Q1 26 | — | $-0.07 | ||
| Q4 25 | $0.48 | $-0.06 | ||
| Q3 25 | $0.84 | $0.07 | ||
| Q2 25 | $0.34 | $0.13 | ||
| Q1 25 | $0.07 | $-0.05 | ||
| Q4 24 | $0.36 | $-0.24 | ||
| Q3 24 | $0.27 | $0.05 | ||
| Q2 24 | $0.52 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | — |
| Total DebtLower is stronger | — | $3.3M |
| Stockholders' EquityBook value | $301.7M | $396.7M |
| Total Assets | $1.7B | $856.4M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $386.7M | — | ||
| Q3 25 | $285.9M | — | ||
| Q2 25 | $222.2M | — | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $271.6M | — |
| Q1 26 | — | $3.3M | ||
| Q4 25 | — | $279.8M | ||
| Q3 25 | — | $281.1M | ||
| Q2 25 | — | $281.5M | ||
| Q1 25 | — | $306.9M | ||
| Q4 24 | — | $281.5M | ||
| Q3 24 | — | $282.8M | ||
| Q2 24 | — | $282.4M |
| Q1 26 | — | $396.7M | ||
| Q4 25 | $301.7M | $405.9M | ||
| Q3 25 | $274.8M | $408.4M | ||
| Q2 25 | $232.2M | $398.4M | ||
| Q1 25 | $234.4M | $381.1M | ||
| Q4 24 | $228.8M | $387.2M | ||
| Q3 24 | $234.3M | $416.6M | ||
| Q2 24 | $216.6M | $408.1M |
| Q1 26 | — | $856.4M | ||
| Q4 25 | $1.7B | $823.2M | ||
| Q3 25 | $1.6B | $844.4M | ||
| Q2 25 | $1.6B | $822.1M | ||
| Q1 25 | $1.6B | $824.6M | ||
| Q4 24 | $1.7B | $794.2M | ||
| Q3 24 | $1.6B | $853.4M | ||
| Q2 24 | $1.1B | $830.0M |
| Q1 26 | — | 0.01× | ||
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.69× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $-47.7M |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-47.7M | ||
| Q4 25 | $123.0M | $23.3M | ||
| Q3 25 | $78.4M | $51.0M | ||
| Q2 25 | $72.4M | $36.0M | ||
| Q1 25 | $55.4M | $-46.9M | ||
| Q4 24 | $84.6M | $6.2M | ||
| Q3 24 | $-9.0M | $37.2M | ||
| Q2 24 | $67.4M | $52.4M |
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | $14.1M | ||
| Q3 25 | $78.3M | $45.2M | ||
| Q2 25 | $72.4M | $29.1M | ||
| Q1 25 | $54.6M | $-50.3M | ||
| Q4 24 | $84.1M | $-98.0K | ||
| Q3 24 | $-9.2M | $33.2M | ||
| Q2 24 | $67.1M | $47.9M |
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | 14.1% | ||
| Q3 25 | 37.4% | 27.9% | ||
| Q2 25 | 38.5% | 16.8% | ||
| Q1 25 | 30.7% | -45.2% | ||
| Q4 24 | 46.2% | -0.1% | ||
| Q3 24 | -5.8% | 22.1% | ||
| Q2 24 | 46.2% | 29.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 9.2% | ||
| Q3 25 | 0.1% | 3.6% | ||
| Q2 25 | 0.0% | 4.0% | ||
| Q1 25 | 0.4% | 3.1% | ||
| Q4 24 | 0.3% | 7.2% | ||
| Q3 24 | 0.2% | 2.7% | ||
| Q2 24 | 0.2% | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | 6.29× | ||
| Q2 25 | 6.05× | 2.25× | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | 6.32× | ||
| Q2 24 | 3.44× | 3.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
